Updates in cancer research: insights from the AACR 100th Annual Meeting

References

• Nicolantonio FD, Sartore-Bianchi A, Molinari F et al.BRAF, PIK3CA, and KRAS mutations and loss of PTEN expression impair response to EGFR-targeted therapies in metastatic colorectal cancer. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract LB-93).
   Google Scholar
• Tykocinski ES, Kapoor GS, Grant R et al. Identification of the EGFRvIII mutation in glioblastoma by magnetic resonance perfusion-weighted imaging and VEGF expression. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract LB-95).
   Google Scholar
• Sorensen AG, Batchelor TT, Ancukiewicz M et al. A “vascular normalization index” as a mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients: insights from a Phase II study. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract LB-94).
   Google Scholar
• Stegmaier K. Gene expression-based approaches to small molecule discovery for cancer. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract SY08-2).
   Google Scholar
• Graves JA, Rothermund K, Prochownik EV. Genomic instability is not required for the acute transforming phenotype of c-Myc. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1885).
   Google Scholar
• Shlien A, Tabori U, Marshall CR et al. Contribution of constitutional DNA copy number variation to the Li-Fraumeni cancer predisposition syndrome and its associated tumors. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1907).
   Google Scholar
• Frank NY, Schatton T, Kim S et al. Functional properties of human melanoma stem cells. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract SY14–3).
   Google Scholar
• Zhu LQ, Gibson P, Currle DS et al. Prominin1/CD133 marks adult intestinal stem cells that are susceptible to neoplastic transformation. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1940).
   Google Scholar
• Idbaih A, Inda M, Ligon AH et al. Transcription factor screening identifies SOX2 as a critical gene in glioblastoma. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1943).
   Google Scholar
• Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer.6, 60 (2007).
   PubMed Web of Science ®Google Scholar
• Ribas J, Ni XH, Haffner M et al. The androgen receptor regulates miR-21 to promote hormone dependent and independent prostate cancer growth. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1962).
   Google Scholar
• Huang V, Jia ZJ, Place RF, Li LC. Small RNA-guided and Ago1-mediated activation of cyclin B1: implication in cancer. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1964).
   Google Scholar
• Cho WC. Cancer research on non-small cell lung cancer in smokers and non-smokers: snapshots from the AACR annual meeting 2009. Cancer Biol. Ther.8(14), 1–4 (2009).
   Google Scholar
• Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur. J. Cancer. doi:10.1016/j.ejca.2009,01.039 (2009) (Epub ahead of print).
   Google Scholar
• Bissell MJ. The importance of the tumor microenvironment in the initiation, promotion, and therapy of cancer. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract PL-4).
   Google Scholar
• Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer9(4), 265–273 (2009).
   PubMed Web of Science ®Google Scholar
• Weinberg RA. The metastatic phenotype. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract SY03-7).
   Google Scholar
• Lu X, Wang QQ, Poznak CV et al. ADAMTS1 and MMP1 promote breast cancer bone metastasis through a bone stromal cell-mediated osteolytic signaling cascade. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 5667).
   Google Scholar
• Karin M. Control of tumor promotion and metastatic progression by inflammatory signaling. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract PL-6).
   Google Scholar
• Harris CC. Inflammation and cancer: microenvironment, cytokines, microRNA, and p53. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Third Annual AACR-Princess Takamatsu Lecture).
   Google Scholar
• Versalovic J. Beneficial microbes: strategies for inflammation and cancer. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract SY39-4).
   Google Scholar
• Murphy EA, Majeti BK, Mukthavaram R, Barnes LA, Wrasidlo W, Cheresh DA. Neovascular targeted lipid-coated nanogel cores as versatile drug carriers. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract SY22-1).
   Google Scholar
• Nie SM, Duan HW, Kuan M. Self-assembled and RES-evading nanoparticles for cancer imaging and therapy. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract SY22-3).
   Google Scholar
• Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer.6, 25 (2007).
   PubMed Web of Science ®Google Scholar
• Cho WC, Cheng CH. Oncoproteomics: current trends and future perspectives. Expert Rev. Proteomics.4(3), 401–410 (2007).
   PubMed Web of Science ®Google Scholar
• Chen R, Pan S, Crispin D et al. Pancreatic cancer protein biomarkers for early detection. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 4735).
   Google Scholar
• Reckamp KL, Patel R, Gitlitz B, Chen L, Jezior D, Zaknoen S. Biomarker based phase I study of apricoxib, a potent COX-2 inhibitor in combination with erlotinib in non-small cell lung cancer (NSCLC) patients. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 5621).
   Google Scholar
• Moran T, Felip-Font E, Torres JM et al. An open label, randomized ph I/IIa trial evaluating MK-0646, an anti-IGF-1R monoclonal antibody, in combination with erlotinib for patients with recurrent non-small cell lung cancer. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 5622).
   Google Scholar
• Sparano JA, Moulder S, Kazi A et al. Phase II trial of the farnesyl transferase inhibitor tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 5624).
   Google Scholar
• Platz EA, Yegnasubramanian S, Liu JO et al. Digoxin users have a lower risk of prostate cancer than non-users in a large prospective cohort study. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1977).
   Google Scholar
• Lee JE, Willett WC, Fuchs CS et al. Folate intake and the risk of colorectal cancer and adenoma in two large prospective studies: modification by time. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 1979).
   Google Scholar
• Vanegas JE, Kocdor M, Pereira JS et al. Mammary cancer prevention by short treatment with human chorionic gonadotropin. Presented at: 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, USA, 18–22 April 2009 (Abstract 2059).
   Google Scholar
• Cho WC. A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research. Ann. Oncol.19(2), 205–211 (2008).
   PubMedGoogle Scholar
• Cho WC. Latest discoveries and trends in translational cancer research: highlights of the 2008 Annual Meeting of the American Association for Cancer Research. Technol. Cancer Res. Treat.7(4), 269–277 (2008).
   PubMed Web of Science ®Google Scholar